FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078283403> ?p ?o ?g. }

• W2078283403 endingPage "450" @default.
• W2078283403 startingPage "442" @default.
• W2078283403 abstract "Transfection of human fibroblast growth factor 9 (FGF-9) cDNA into mouse BALB/c 3T3 clone A31 cells led to morphological transformation of the cells and foci formation 4 weeks later. Isolated transformants had a higher saturation density than parental A31 cells, could grow in soft agar, and secreted FGF-9 into the culture supernatant. The introduction of FGF-9 N33 cDNA, which encodes a truncated protein that has 33 N-terminal amino acids deleted and has the same mitogenic potency as FGF-9, failed to lead to foci formation. Although FGF-9 is a secretory protein, it does not have a typical secretory signal sequence, and the secreted protein retains the full sequence coded in the cDNA except for the initiating methionine. The produced FGF-9 N33 was not secreted and remained within the cell. It is possible that FGF-9 has an uncleavable signal sequence within the first 33 N-terminal amino acids. All of the phenotypes acquired by transformation could be arrested by treatment with a neutralizing anti-human FGF-9 monoclonal antibody (MAb) 150-59. Additionally, transformants formed tumors in nude mice. Injection of MAb 150-59 suppressed tumor formation in nude mice and caused existing tumors to regress. Our results suggest that the cellular transformation mediated by FGF-9 is produced by autocrine stimulation. We have detected FGF-9 production in the human tumor cell lines glioma NMC-G1, from which FGF-9 was originally purified, and stomach carcinoma AZ-521. The growth of NMC-G1 was not affected by MAb 150-59, but that of AZ-521 was arrested by MAb 150-59 in the presence of heparin. Moreover, the growth of the AZ-521 cell tumor in nude mice could be partially arrested by antibody treatment. The possibility of a participation of FGF-9 in the formation of human tumors is suggested. Int. J. Cancer 71:442-450, 1997. © 1997 Wiley-Liss Inc." @default.
• W2078283403 created "2016-06-24" @default.
• W2078283403 creator A5027531628 @default.
• W2078283403 creator A5031617886 @default.
• W2078283403 creator A5055032942 @default.
• W2078283403 creator A5066616918 @default.
• W2078283403 creator A5069319914 @default.
• W2078283403 date "1997-05-02" @default.
• W2078283403 modified "2023-09-29" @default.
• W2078283403 title "Autocrine transformation by fibroblast growth factor 9 (FGF-9) and its possible participation in human oncogenesis" @default.
• W2078283403 cites W1582678267 @default.
• W2078283403 cites W1659132057 @default.
• W2078283403 cites W1784257340 @default.
• W2078283403 cites W1796421249 @default.
• W2078283403 cites W1948307417 @default.
• W2078283403 cites W1972068426 @default.
• W2078283403 cites W1974027176 @default.
• W2078283403 cites W2017724386 @default.
• W2078283403 cites W2034185792 @default.
• W2078283403 cites W2036488491 @default.
• W2078283403 cites W2039358114 @default.
• W2078283403 cites W2042202567 @default.
• W2078283403 cites W2046756969 @default.
• W2078283403 cites W2049124768 @default.
• W2078283403 cites W2053280162 @default.
• W2078283403 cites W2055828195 @default.
• W2078283403 cites W2068801415 @default.
• W2078283403 cites W2073323729 @default.
• W2078283403 cites W2095346194 @default.
• W2078283403 cites W2105994871 @default.
• W2078283403 cites W2138354687 @default.
• W2078283403 cites W2151598389 @default.
• W2078283403 cites W2163398206 @default.
• W2078283403 cites W4250190568 @default.
• W2078283403 cites W46286177 @default.
• W2078283403 cites W81411684 @default.
• W2078283403 doi "https://doi.org/10.1002/(sici)1097-0215(19970502)71:3<442::aid-ijc23>3.0.co;2-g" @default.
• W2078283403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9139882" @default.
• W2078283403 hasPublicationYear "1997" @default.
• W2078283403 type Work @default.
• W2078283403 sameAs 2078283403 @default.
• W2078283403 citedByCount "28" @default.
• W2078283403 countsByYear W20782834032012 @default.
• W2078283403 countsByYear W20782834032013 @default.
• W2078283403 countsByYear W20782834032014 @default.
• W2078283403 countsByYear W20782834032015 @default.
• W2078283403 countsByYear W20782834032016 @default.
• W2078283403 countsByYear W20782834032020 @default.
• W2078283403 crossrefType "journal-article" @default.
• W2078283403 hasAuthorship W2078283403A5027531628 @default.
• W2078283403 hasAuthorship W2078283403A5031617886 @default.
• W2078283403 hasAuthorship W2078283403A5055032942 @default.
• W2078283403 hasAuthorship W2078283403A5066616918 @default.
• W2078283403 hasAuthorship W2078283403A5069319914 @default.
• W2078283403 hasBestOaLocation W20782834031 @default.
• W2078283403 hasConcept C104317684 @default.
• W2078283403 hasConcept C128240485 @default.
• W2078283403 hasConcept C153911025 @default.
• W2078283403 hasConcept C170493617 @default.
• W2078283403 hasConcept C187882448 @default.
• W2078283403 hasConcept C2775960820 @default.
• W2078283403 hasConcept C31033888 @default.
• W2078283403 hasConcept C502942594 @default.
• W2078283403 hasConcept C54009773 @default.
• W2078283403 hasConcept C54355233 @default.
• W2078283403 hasConcept C55493867 @default.
• W2078283403 hasConcept C555283112 @default.
• W2078283403 hasConcept C74373430 @default.
• W2078283403 hasConcept C81089528 @default.
• W2078283403 hasConcept C81885089 @default.
• W2078283403 hasConcept C86803240 @default.
• W2078283403 hasConceptScore W2078283403C104317684 @default.
• W2078283403 hasConceptScore W2078283403C128240485 @default.
• W2078283403 hasConceptScore W2078283403C153911025 @default.
• W2078283403 hasConceptScore W2078283403C170493617 @default.
• W2078283403 hasConceptScore W2078283403C187882448 @default.
• W2078283403 hasConceptScore W2078283403C2775960820 @default.
• W2078283403 hasConceptScore W2078283403C31033888 @default.
• W2078283403 hasConceptScore W2078283403C502942594 @default.
• W2078283403 hasConceptScore W2078283403C54009773 @default.
• W2078283403 hasConceptScore W2078283403C54355233 @default.
• W2078283403 hasConceptScore W2078283403C55493867 @default.
• W2078283403 hasConceptScore W2078283403C555283112 @default.
• W2078283403 hasConceptScore W2078283403C74373430 @default.
• W2078283403 hasConceptScore W2078283403C81089528 @default.
• W2078283403 hasConceptScore W2078283403C81885089 @default.
• W2078283403 hasConceptScore W2078283403C86803240 @default.
• W2078283403 hasIssue "3" @default.
• W2078283403 hasLocation W20782834031 @default.
• W2078283403 hasLocation W20782834032 @default.
• W2078283403 hasOpenAccess W2078283403 @default.
• W2078283403 hasPrimaryLocation W20782834031 @default.
• W2078283403 hasRelatedWork W2171605700 @default.
• W2078283403 hasRelatedWork W2352258017 @default.
• W2078283403 hasRelatedWork W2358712227 @default.
• W2078283403 hasRelatedWork W2364319975 @default.
• W2078283403 hasRelatedWork W2371227049 @default.
• W2078283403 hasRelatedWork W2376774677 @default.

• next